Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Jeevan R. Kunta"'
Autor:
Cosette J. Serabjit-Singh, Jarkko Rautio, Lindsey O. Webster, Jeevan R. Kunta, Joseph W. Polli, John P. Keogh, Anand Balakrishnan, Joan E. Humphreys
Publikováno v:
Drug Metabolism and Disposition. 34:786-792
Because modulation of P-glycoprotein (Pgp) through inhibition or induction can lead to drug-drug interactions by altering intestinal, central nervous system, renal, or biliary efflux, it is anticipated that information regarding the potential interac
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 310:359-366
The current study was performed in intestinal and vascular access ported rabbits to quantify and differentiate the components of intestinal and hepatic first pass extraction (i.e., metabolism and secretion) of saquinavir (SQV) mediated by P-glycoprot
Autor:
Jeevan R. Kunta, Patrick J. Sinko
Publikováno v:
Current Drug Metabolism. 5:109-124
The oral route of drug administration remains the most popular and convenient route of administration, despite its many shortcomings and challenges. Although the advantages associated with this route far outweigh any limitations, a prominent limitati
Autor:
John P. Sutyak, Jeevan R. Kunta, Yong-Hee Lee, Hee Sang Lee, Barbara A. Perry, Patrick J. Sinko
Publikováno v:
Pharmaceutical Research. 18:1721-1728
Purpose. To investigate the relative contributions of the gut and liver to the first-pass loss of verapamil (VL) using anin vivo intestinal-vascular access port (IVAP) dog model.
Publikováno v:
Biopharmaceutics & Drug Disposition. 21:83-93
The aim of the present study was to investigate the directional transport kinetics of etoposide in rabbit intestinal tissues using side-by-side diffusion chambers. Etoposide is a routinely used mixed-mechanism 'efflux' inhibitor; however, its absorpt
Autor:
Jeevan R. Kunta, John P. Keogh
Publikováno v:
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 27(5)
Regulatory interest is increasing for drug transporters generally and P-glycoprotein (Pgp) in particular, primarily in the area of drug-drug interactions. To aid in both identifying and discharging the potential liabilities associated with drug-trans
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals. 32(11)
Low and varied oral bioavailability (BA) of some drugs has been attributed to extraction by the intestine and liver. However, the role of the intestine is difficult to directly assess. We recently developed an in vivo intestinal and vascular access-p
Publikováno v:
Optimization in Drug Discovery: In Vitro Methods; 2014, pi-xvii, 17p
Autor:
Volpe, Donna
Publikováno v:
AAPS Journal; Oct2010, Vol. 12 Issue 4, p670-678, 9p, 6 Charts, 8 Graphs
Publikováno v:
Pharmaceutical Research; Mar2011, Vol. 28 Issue 3, p421-422, 2p